(Q40536014)

21 September 2017

title

Adolescent vaccination in the developing world: time for serious consideration? (English)

1 reference

21 September 2017

1 reference

Warren Stevens

1

1 reference

21 September 2017

Damian Walker

series ordinal

2

1 reference

21 September 2017

language of work or name

English

0 references

publication date

1 January 2004

1 reference

21 September 2017

number of pages

5

1 reference

based on heuristic

inferred from page(s)

published in

Vaccine

1 reference

21 September 2017

volume

22

1 reference

21 September 2017

issue

5-6

1 reference

21 September 2017

page(s)

781-785

1 reference

Infant and adolescent hepatitis B immunization up to 1999: a global overview

21 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.05.001

Epidemiological features of pertussis in the United States, 1980-1989.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.05.001

Tetanus antibody levels among adolescent girls in developing countries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.05.001

Observational study of vaccine efficacy 14 years after trial of hepatitis B vaccination in Gambian children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.05.001

Association of herpes simplex virus type 2 with the human immunodeficiency virus among urban women in Zimbabwe

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.05.001

Risk of human immunodeficiency virus infection in herpes simplex virus type 2-seropositive persons: a meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.05.001

Exposure to varicella boosts immunity to herpes-zoster: implications for mass vaccination against chickenpox

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.05.001

Cost of School-based Drug Treatment in Tanzania

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.05.001

An investigation into the interaction between drug efficacy and drug price of praziquantel in determining the cost-effectiveness of school-targeted treatment for Schistosoma mansoni using a population dynamic model.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.05.001

Malaria diagnosis and treatment administered by teachers in primary schools in Tanzania

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.05.001

A school-based schistosomiasis and intestinal helminthiasis control programme in Nigeria: acceptability to community members

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.05.001

Developing strategies to control schistosomiasis morbidity in nonenrolled school-age children: experience from Egypt

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.05.001

A population dynamic approach to evaluating the impact of school attendance on the unit cost and effectiveness of school-based schistosomiasis chemotherapy programmes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.05.001

10.1016/J.VACCINE.2003.05.001

7 January 2021

Identifiers

DOI

1 reference

21 September 2017

1 reference